TuHURA Biosciences (HURA) Goodwill (2025 - 2026)

TuHURA Biosciences' (HURA) quarterly Goodwill came in at $10.7 million in Q1 2026, little changed quarter-over-quarter from $10.7 million in Q4 2025.

TuHURA Biosciences (HURA) Goodwill (2025 - 2026) Analysis & Trends

TuHURA Biosciences' Goodwill history runs 2 years deep, the most recent figure standing at $10.7 million for Q1 2026.

On a quarterly basis, Goodwill changed N/A year-over-year to $10.7 million in Q1 2026; TTM through Mar 2026 was $10.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at $10.7 million, changed N/A from the prior year.
Goodwill held at $10.7 million in Q1 2026 per HURA's latest filing, from $10.7 million in the prior quarter.
Across five years, Goodwill topped out at $13.6 million in Q3 2025 and bottomed at $10.7 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-
10	TuHURA Biosciences	132.62 Mn	132.62 Mn	-

Download Data